Hotline:86-10-67887855 
简体中文Nafcillin Sodium for injection has been approved by China SF
Release time：2022-11-17 15:16:22
Our new formulation Nafcillin Sodium for injection (1.0gram per ampoule)
has been approved by China SFDA on 4th May 2015. The API registration
certificate no. is H20153081 and its injection registration certificate
no. is H20153082.
Reprint statement: reprint please indicate "source: Wista pharma".
Recommend
-
2022-11-17Olopatadine hydrochloride tablets has been approved by China SF
-
2022-11-17
Nafcillin Sodium for injection has been approved by China SF
-
2022-11-17Luliconazole and posaconazole are launched into market
-
2022-11-17Voriconazole tablets has been approved by China SF
-
2022-11-17Our new formulation L-Ornithine-L-Aspartate Infusion for injection has been approved
86-10-67887855
Head Office：
Marketing：
Wista Pharmam
86-10-67887855